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A B S T R A C T 
Bovine leukemia virus (BLV) is a retrovirus that causes lymphosarcoma in cattle. Some researchers suggest 
that BLV could be related to breast cancer development, however, evidence that the virus can infect the 
human counterpart is lacking. For that reason, the objective of this study was to infect in vitro a human 
mammary epithelial cell line (MCF10A) with BLV. The results suggest that the infection is non-productive, 
since only a fragment of the viral gene pol was detected in the cellular DNA. These results are consistent 
with previous studies, where fragments of different BLV genes were found in human mammary tissue. 
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Impacts 
 
Bovine leukemia virus can infect a human mammary epithelial cell line 
and is integrated as a provirus. BLV infection on human mammary 
epithelial cell line (MCF10A) is not productive. BLV non-productive 
infection of the human mammary epithelial cells can be involved in 




Bovine leukemia virus (BLV) is a δ-retrovirus that affects cattle causing 
a lymphoproliferative disease. Its main target cell is the B lymphocyte 
but, naturally and experimentally, this virus can infect other cells such 
as neutrophils, epithelial and brain cells [1-4]. Since the detection of 
BLV in bovine epithelial mammary cells, researchers have considered 
the possibility of this virus infecting human epithelial mammary cells [2, 
5, 6]. Many facts support this idea. First, BLV belongs to the same viral 
family that the human T lymphotropic virus (HTLV). This is a 
carcinogenic virus in humans and shares structural and functional 
homology with BLV [7]. Although the BLV receptor in cattle is not yet 
elucidated, it is believed that it is a protein from the adaptor-related 
protein complex 3 (AP-3) [8]. This protein is also present in humans, 
who have four different AP complex. The fact that the putative receptor 
of the virus has 88% homology with the human counterpart and that the 
putative binding site for the viral protein gp51 is completely homologous 
in both species support the possibility of BLV infecting humans [9]. 
 
Virus have been associated with the development of different tumors in 
humans. It is believed that around 12% of the cancer cases are from viral 
origin [10]. The possible role of BLV in the development of human 
breast cancer has been investigated in the past years with controversial 
results [11-15]. Numerous studies have detected fragments of viral genes 
and proteins in human breast samples using different techniques such as 
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in situ PCR, immunohistochemistry, and conventional PCR [13-18]. 
Most of these studies suggest that the virus might be implicated in the 
onset or development of human breast cancer. However, to our 
knowledge, no study unequivocally demonstrates whether the virus can 
infect human breast cells. Confirming that the virus can infect human 
mammary cells is the first step to analysing the possible relationship 
between the virus and the development of human breast cancer. Thus, 
the aim of this study was to infect in vitro a human mammary epithelial 
cell line (MCF10A) and analyse its effects. 
 
Materials and Methods 
 
BLV was obtained from BLV-infected adult cows in the Manhattan area 
(Kansas, USA). From each animal, 20 ml of heparinized blood (5 U ml-
1) were obtained by jugular venipuncture. Peripheral blood mononuclear 
cells (PBMCs) were isolated using SepMate™ (STEMCELL 
Technologies Inc, Canada) and Ficoll-Paque™ PREMIUM (GE 
Healthcare) following the manufacturer´s instructions. PBMCs were 
cultivated in RPMI supplemented with 10 % FBS by incubating at 37°C 
with 5% CO2 until use.  
 
For MCF10A infection, forty thousand cells were seeded in each well of 
a six well plate and cultured until they reached 90% confluence. The 
cells were co-cultured with 1 x 10 5 PBMCs from the infected animals 
for 24 h. After that time, cells were passaged three times (to passage 3 
post infection; 3 ppi) and started to be analysed. The experiment was 
conducted in triplicate using PBMCs from three different animals. The 
infected cell line was designated MCF10A BLV. DNA was extracted 
from cell pellets using Qiagen columns (QIAamp DNA Mini Kit, 
Germantown, MD, USA) according to the manufacturer's protocol. DNA 
concentration and purity were determined by absorbance at 260 nm and 
260/280 coefficient, respectively, in a NanoDrop 2000 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). 
Purified DNAs were stored at -20 ºC until use. 
 
Obtained DNA was used as a template to amplify the viral gene pol, as 
well as the human and bovine GAPDH by conventional PCR. All three 
PCR reactions were performed in a final volume of 25 µl containing 12.5 
µl of GoTaq MasterMix (Promega®), 0.4 mM primers and 1 µl of the 
template. The primers and PCR program used for pol and hGAPDH were 
described previously [16, 19]. For bGAPDH amplification the primers 
used were F: 5´ TGTTGTGGATCTGACCTGCC 3´ R:5´ 
TGAAGGGCTGTTTACCGAGC 3´ and the amplification was 
performed 2 min at 95°C, 35 cycles of 30 s 95°C, 30 s 50°C and 22 s 
72°C ending with 5 min 72°C. The PCR products and a 1 Kb DNA ladder 
were run in a 1% agarose gel and visualized using ethidium bromide.  
 
RNA was extracted from cell culture supernatants and pellets using 
MagMAX™-96 Viral RNA Isolation kit (Applied Biosystems, USA) 
following the manufacturer's instructions. Obtained RNA was used as a 
template to amplify the viral gene pol by RT PCR using SuperScript™ 
III One-Step RT-PCR System with Platinum™ Taq DNA Polymerase 
(Invitrogen, Thermo Scientific, Waltham, MA, USA) and the primers 
described previously [19]. The program included a cycle of 30 min 50°C 
and 2 min 94°C; followed by 8 cycles of 1 min 94°C, 1 min 55°C and 1 
min 72°C; 25 cycles of 1 min 94°C, 1 min 62°C and 1 min 72°C and a 
final extension of 10 min72°C. The PCR products and a 1 Kb DNA 
ladder were run in a 1% agarose gel and visualized using ethidium 
bromide. For DNase treatment, DNase I, RNase-free (Thermo Scientific, 
Waltham, MA, USA) was used, following the manufacturer´s 
instructions. 
 
In order to detect the viral protein p24 in cell culture pellets and 
supernatants, a western blot was performed. Cell cultures pellets were 
lysated using 20 mM Tris-HCl, pH 7.5 and heated at 100°C for 10 min. 
Cell culture supernatants and lysates were run in 12% w/v denaturalizing 
polyacrylamide gels and transferred onto AmershamTM HybondTM 0.2 
µm PVDF (GE Healthcare Life Sciences). After 1 h blocking with 
MTBS, the membrane was incubated 1 h with an anti-BLV p24 
monoclonal antibody (1:100) (NIH AIDS Reagent Program), washed 3 
times for 15 min each with PBS-Tween and incubated with 1:500 
peroxidase labeled goat anti-mouse IgG (Seracase) for 1 h. The 
membrane was washed with PBS and incubated for 5 min with CN/DAB 
substrate 10x (Thermo Fisher Scientific) to develop the reaction and 
stopped by rinsing with tap water. 
 
Cell viability was analysed using MTT. For that purpose, ten thousand 
cells were seeded in each well of a 96 well plate and incubated 48 h at 
37°C. Twenty microliters of MTT solution (5 mg ml-1) (Sigma-Aldrich) 
were added to each well. After 4 h incubation, the plate was centrifuged 
at 2000 rpm 2 min and the formazan crystals were resuspended using 
200 μl of DMSO (MP Biomedicals). The absorbance was determined at 
570 nm using an Epoch Microplate Spectrophotometer (BioTek). 
Results are express as % of the non-infected MCF10A cells. The 
experiment was repeated 3 times with four technical replicates each time. 
The statistical analysis was performed in R using ANOVA test. 
 
Results and Discussion 
 
Our results show that human mammary cell line MCF10A can be 
infected with BLV in vitro. The new cell line called MCF10A BLV 
resulted from the infection of MCF10A with PBMC from highly BLV 
infected cows. The analysis of this new cell line began at passage 3 ppi 
when genomic DNA was extracted, and a fragment of the viral gene pol 
was detected by conventional PCR. DNA obtained from MCF10A BLV 
and the positive control amplified a unique fragment of the expected size 
of 184 pb (Figure 1). Moreover, when using MCF10A BLV DNA as a 
template, only human and not bovine GAPDH could be amplified, 
dismissing the possibility that the fragment of the pol gene detected in 











Figure 1: A fragment of BLV pol gene and human GAPDH was 
amplified in MCF10A BLV genomic DNA. A) PBMCs DNA from a 
naturally infected cow used for MCF10A infection, B) MCF10A DNA, 
C) MCF10A BLV DNA. 
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The 24 kDa viral protein was not detected in cells supernatant which 
suggest that the new cell line does not release viral particles into the cell 
culture supernatant. Considering the possibility that the viral protein p24 
was synthesized but unable to be released, cell pellets were lysed for 
analysis. The protein was not detected by Western blot in the cell lysates 
nor was it found in MCF10A-BLV supernatant (Figure 2a). The absence 


















Figure 2: a) Western blot analysis of viral protein p24 in cell culture supernatants and pellets lysates. A) MW marker. B) positive control, MAC-T BLV 
32ppi supernatant. C) MCF10A BLV 24ppi supernatant D) MCF10A BLV 24ppi pellet lysate. E) MCF10A BLV 18ppi supernatant. F) MCF10A BLV 18 
ppi pellet lysate. G) MCF10A pellet lysate. b) Viral RNA is not detected in MCF10A BLV cell pellets. RT-PCR was performed to detect viral gene pol in 
cell pellets. A) Molecular weight marker. B) pellet MCF10A BLV 26 ppi treated with DNase. C) pellet MCF10A BLV 16 ppi treated with DNase. D) pellet 
MAC-T BLV 19 ppi treated with DNase. E) pellet MCF10A BLV 26 ppi. F) pellet MCF10A BLV 16 ppi. G) pellet MAC-T BLV 19 ppi. 
 
To confirm that the cells were not releasing virus, an RT-PCR assay was 
carried out to detect RNA from the viral gene pol in cell culture 
supernatants and pellets. No amplification was observed in the 
supernatants (data not shown). To analyse the presence of the viral gene 
in cell pellets, a kit that extracted both viral DNA and RNA was used 
(MagMAX™-96 Viral RNA Isolation kit). When these nucleic acids 
were analysed by RT-PCR, the fragment of a viral gene pol was 
amplified. However, when a DNase treatment was carried out before the 
RT-PCR, amplification of the pol fragment was no longer detectable 
(Figure 2b). Cell viability analysed by MTT showed no difference 
between BLV infected and uninfected MCF10A (p = 0.2857) for at least 
33 ppi. It is known that non-productive infections could play a role in 
tumor development [20]. Although the virus cannot generate new 
infective viral particles, it can produce proteins that interfere with the 
normal cell cycle.  
 
Our results show that BLV infected human epithelial breast cells have 
no difference in cell viability compared to the uninfected cells when 
measured by MTT. The reason for this lack of effect on the cell viability 
could be that the cells were not infected for enough time to suffer 
significant changes. Previous studies that analysed the presence of the 
virus in human mammary tissue found that the viral DNA fragments 
were present in healthy individuals up to 10 years before the 
development of breast cancer [14]. This suggests that if BLV does play 
a role in breast cancer tumorigenesis, it likely progresses very slowly and 
the effect of the virus on cell viability will not be evident for a long time. 
Moreover, in most virus-related cancer, the presence of the virus is not 
the only condition necessary to develop the tumor. Other factors such as 
immunosuppression, chronic inflammation, and spontaneous mutations 
contribute to the outcome. This could also explain why we did not find 
any difference in cell viability in vitro.  
In summary, we have infected a human mammary cell line with BLV in 
vitro. The new cell line does not release viral particles into the cell 
culture supernatant. Nevertheless, viral DNA was detected in the 
mammary epithelial cell genome. Previous studies indicate that the 
difference between BLV productive and non-productive infection is the 
efficiency in the reverse transcription [21]. In this case, we demonstrated 
that the virus is integrated, which indicates that the reverse transcription 
is not the critical step for BLV replication in this cell line. Moreover, it 
is well known that retrovirus expression can be repressed by epigenetic 
mechanisms both in natural and interspecies infections [22]. This could 
also explain the fact that no viral proteins were detected in MCF10A 
BLV cells supernatants. 
 
More research needs to be done to elucidate if BLV plays a role in human 
breast cancer. The fact that we were able to detect a fragment of the viral 
gene pol in the MCF10A DNA is consistent with previous studies that 
detected other gene fragments by PCR and in situ PCR. Although the 
infection in MCF10A was not productive, we cannot disregard the 
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